1999
DOI: 10.1046/j.1464-410x.1999.00397.x
|View full text |Cite
|
Sign up to set email alerts
|

The pharmacological treatment of urinary incontinence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
186
0
14

Year Published

2002
2002
2009
2009

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 219 publications
(201 citation statements)
references
References 299 publications
1
186
0
14
Order By: Relevance
“…Botulinum neurotoxin type A (BoNT/A) injections into the detrusor muscle is a recommended therapy for neurogenic detrusor overactivity (NDO), when antimuscarinic drug therapy failed or is not tolerated [1][2][3][4]. BoNT/A injections have been successfully used to treat NDO worldwide and further indications and therapy options are currently explored [5][6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…Botulinum neurotoxin type A (BoNT/A) injections into the detrusor muscle is a recommended therapy for neurogenic detrusor overactivity (NDO), when antimuscarinic drug therapy failed or is not tolerated [1][2][3][4]. BoNT/A injections have been successfully used to treat NDO worldwide and further indications and therapy options are currently explored [5][6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…Gesetz den Fall, die OAB-Symptomatik verbleibt nach Ausschluß anderweitiger Ursachen als "idiopathisch", gibt es verschiedene Theorien der Ursachen: eine konzentriert sich auf direkt myogene Ursachen (Brading, 1997) (Andersson et al, 2005).…”
Section: Pathologie Und Pathophysiologie Der Oabunclassified
“…Behandlung der OAB ausgegeben (Andersson et al, 2005). Neuere Medikamente dieser Stoffgruppe sind Darifenacin (Hill et al, 2007) und Fesoterodine (Nitti et al, 2007).…”
Section: Medikamentöse Therapieunclassified
“…A committee of experts in incontinence met in July 2001 at the 2nd International Consultation on Incontinence (ICI) in Paris to discuss the principles of treatment of urinary incontinence, including the overactive bladder and polyuria [5]. This committee evaluated the literature on drugs affecting bladder function, particularly those able to increase bladder capacity and reduce storage symptoms.…”
Section: Evaluation Of the Effectiveness Of Treatments For Nocturiamentioning
confidence: 99%